MVIS US Listed Pharmaceutical 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that derive at least 50% of their revenues from pharmaceuticals. The pure-play index contains only companies which are engaged primarily engaged in research (incl. research contractors) and development as well as production, marketing and sales of pharmaceuticals. Pharmacies are excluded. The MVIS US Listed Pharmaceutical 25 Index (MVPPH) has been licensed to underlie financial products with currently USD 329.8 million in assets under management.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
ASTRAZENECA PLC-SPONS ADRGB5.67%
NOVO-NORDISK A/S-SPONS ADRDK5.37%
ELI LILLY & COUS5.22%
PFIZER INCUS5.21%
JOHNSON & JOHNSONUS5.03%
MERCK & CO. INC.US5.03%
BRISTOL-MYERS SQUIBB COUS5.02%
ZOETIS INCUS5.00%
ABBVIE INCUS4.94%
NOVARTIS AG-ADRCH4.85%
SANOFI-ADRFR4.73%
MCKESSON CORPUS4.66%
CATALENT INCUS4.63%
AMERISOURCEBERGEN CORPUS4.53%
GLAXOSMITHKLINE PLC-SPON ADRGB4.42%
TAKEDA PHARM-ADRJP4.21%
VIATRIS INCUS3.97%
ELANCO ANIMAL HEALTH INCUS3.60%
TEVA PHARMACEUTICAL-SP ADRIL3.35%
BAUSCH HEALTH COS INCCA2.94%
JAZZ PHARMACEUTICALS PLCIE2.71%
ORGANON & COUS2.22%
PERRIGO CO PLCIE1.57%
PATTERSON COMPANIES INCUS0.56%
AMARIN CORPORATION PLC -ADRGB0.55%
Items 1-25 of total 25
Up